Expression of Concern to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Expression of Concern to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Bibliographic Details
Main Authors:	Huan Yang, Peter Lundbäck, Lars Ottosson, Helena Erlandsson-Harris, Emilie Venereau, Marco E. Bianchi, Yousef Al-Abed, Ulf Andersson, Kevin J. Tracey, Daniel J. Antoine
Format:	Article
Language:	English
Published:	BMC 2020-02-01
Series:	Molecular Medicine
Online Access:	https://doi.org/10.1186/s10020-020-0144-8

Similar Items

Redox modifications of cysteine residues regulate the cytokine activity of HMGB1
by: Huan Yang, et al.
Published: (2021-06-01)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
by: Huan Yang, et al.
Published: (2019-04-01)

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
by: Karin Palmblad, et al.
Published: (2020-02-01)

HMGB1 redox during sepsis
by: Wasan Abdulmahdi, et al.
Published: (2017-10-01)

Ligation of free HMGB1 to TLR2 in the absence of ligand is negatively regulated by the C-terminal tail domain
by: Hannah Aucott, et al.
Published: (2018-05-01)

Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation
by: Ulf Andersson, et al.
Published: (2021-11-01)

Targeting Inflammation Driven by HMGB1
by: Huan Yang, et al.
Published: (2020-03-01)

Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome
by: Karin Palmblad, et al.
Published: (2020-12-01)

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
by: Ulf Andersson, et al.
Published: (2020-05-01)

Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions
by: Michele Ferrara, et al.
Published: (2020-06-01)

Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance
by: Mingzhu He, et al.
Published: (2018-05-01)

Correction to: Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance
by: Mingzhu He, et al.
Published: (2018-06-01)

HMGB1 is a critical molecule in the pathogenesis of Gram-negative sepsis
by: Ulf Andersson, et al.
Published: (2022-07-01)

Neurons Are a Primary Driver of Inflammation via Release of HMGB1
by: Huan Yang, et al.
Published: (2021-10-01)

Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis
by: John D. Lee, et al.
Published: (2019-02-01)

Redox State-Dependent Interaction of HMGB1 and Cisplatin-Modified DNA
by: Park, SeMi, et al.
Published: (2012)

Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology
by: Man Sup Kwak, et al.
Published: (2020-06-01)

Binding of histone H1 to DNA is differentially modulated by redox state of HMGB1.
by: Eva Polanská, et al.
Published: (2014-01-01)

Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
by: Ruochan Chen, et al.
Published: (2013-11-01)

Developmental expression of high-mobility group box 1 (HMGB1) in the mouse cochlea
by: Wenjing Liu, et al.
Published: (2023-09-01)

Role of high mobility group box 1 (HMGB1) in SCA17 pathogenesis.
by: Li-Ching Lee, et al.
Published: (2014-01-01)

The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes.
by: Knapp, S, et al.
Published: (2004)

Sequestering HMGB1 via DNA-conjugated beads ameliorates murine colitis.
by: Zhongliang Ju, et al.
Published: (2014-01-01)

A Redox-Sensitive Cysteine Is Required for PIN1At Function
by: Benjamin Selles, et al.
Published: (2021-12-01)

Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
by: Yan Sun, et al.
Published: (2018-07-01)

Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis
by: Valentina Cecchinato, et al.
Published: (2018-09-01)

High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy
by: Bram DeWulf, et al.
Published: (2023-04-01)

High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
by: Shunling Yuan, et al.
Published: (2020-07-01)

Thermodynamics of HMGB1 interaction with duplex DNA.
by: Müller, S, et al.
Published: (2001)

Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screening.
by: Domokos Gerö, et al.
Published: (2013-01-01)

Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses.
by: Edward A Arnold, et al.
Published: (2023-09-01)

Diagnostic Value of High-Mobility Group Box 1 (HMGB1) Protein in Acute and Perforated Appendicitis
by: Shabanali Alizadeh, et al.
Published: (2018-01-01)

High mobility group box 1 protein (HMGB1) stimulates the nuclear accumulation of p53
by: Maria Schröder, et al.
Published: (2019-01-01)

The potential roles of high mobility group box 1 (HMGB1) in musculoskeletal disease: a systematic review
by: Gacaferi, H, et al.
Published: (2020)

High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression
by: Inna M. Yasinska, et al.
Published: (2018-06-01)

Correction: The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis.
by: Rogelio Hernández-Pando, et al.
Published: (2015-01-01)

DAMPs from death to new life
by: Emilie eVénéreau, et al.
Published: (2015-08-01)

Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function.
by: Müller, S, et al.
Published: (2004)

HMGB-1 in Psoriasis
by: Marco Casciaro, et al.
Published: (2021-12-01)

Inhibition of inflammatory liver injury by the HMGB1-A box through HMGB1/TLR-4/NF-κB signaling in an acute liver failure mouse model
by: Lidan Luo, et al.
Published: (2022-10-01)